![Weekly Enforcement Report: UDTs & Diagnostic Imaging](https://www.g2intelligence.com/wp-content/uploads/2023/03/March22-2023.News_.WeeklyEnforcementReportUDTs-iStock-1800x1250-1-1080x675.jpg)
Weekly Enforcement Report: UDTs & Diagnostic Imaging
This week’s cases involved false billing allegations related to urine drug testing, as well as diagnostic imaging false claims and fraud.
This week’s cases involved false billing allegations related to urine drug testing, as well as diagnostic imaging false claims and fraud.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.
Though last week’s cases didn’t involve labs or lab testing, most were FCA-related issues including inflated claims.